FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RXQ Compounding methylPREDNIsolone ACETATE Recall

methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding,…

RXQ Compounding LLC · Athens, OH

Risk level
Class II
Reported by FDA
Oct 25, 2017
Recall ID
D-0012-2018
Check your lot numberHow we source this data

Summary

RXQ Compounding recalled methylPREDNIsolone ACETATE starting Sep 25, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0012-2018 on Oct 25, 2017. Reason: Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

Product description

methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10

Lot numbers, UPCs & expiration codes

Lot: 04252017@1, exp 5/9/2018

Where it was sold

TX, LA, PA, MA, FL, and OH

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0012-2018
Classification
Class II
Status
Terminated
Recall initiated
Sep 25, 2017
FDA report date
Oct 25, 2017
Quantity
945 vials
Recall type
Voluntary: Firm initiated
Recalling firm
RXQ Compounding LLC

Original FDA data

Every field from FDA enforcement report D-0012-2018, exactly as published.

Show all FDA fields
City
Athens
State
OH
Status
Terminated
Country
United States
Event ID
78175
Address
340 W State St Unit 9
Code information
Lot: 04252017@1, exp 5/9/2018
Postal code
45701-1564
Report date
Oct 25, 2017
Product type
Drugs
Recall number
D-0012-2018
Classification
Class II
Recalling firm
RXQ Compounding LLC
Product quantity
945 vials
Termination date
Dec 6, 2017
Reason for recall
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
Distribution pattern
TX, LA, PA, MA, FL, and OH
Recall initiation date
Sep 25, 2017
Initial firm notification
Telephone
Center classification date
Oct 18, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0012-2018, published Oct 25, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls